PELICAN-IPC 2015–016/Oncodistinct-003: A randomized non-comparative phase II study of pembrolizumab in combination with neoadjuvant chemotherapy in HER2-negative inflammatory breast cancer

European Journal of Cancer · Elsevier

Аннотация

Publication date: 9 December 2026 Source: European Journal of Cancer, Volume 249 Author(s): Alexandre de Nonneville, Florence Lerebours, Christophe Zemmour, Florence Dalenc, Christelle Levy, Thierry Petit, Marianne Leheurteur, Jean-Yves Pierga, Thomas Bachelot, Sylvain Ladoire, Frédéric Viret, Leonor Lopez Almeida, Muge Kaya, Jean-Marie Boher, François Bertucci, Emmanuelle Charafe, Anthony Gonçalves

Читать у издателя →

Похожие статьи